[Skip to Content]
[Skip to Content Landing]
August 19, 1968

Evaluation of a New Antipsychotic Agent: Haloperidol (Haldol)

JAMA. 1968;205(8):577-578. doi:10.1001/jama.1968.03140340047011

Haloperidol is effective in the treatment of symptoms of hyperactivity in patients with psychotic disorders, including schizophrenia and the manic phase of manic-depressive disorder. Extrapyramidal symptoms are the most common adverse effects and occur most frequently when large doses are used.